Drug intelligence / Profile preview

technetium Tc 99m albumin

Development stage
Unknown
Lead developer
Curium
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Submucosal, Peritumoral, Intraperitoneal, Inhalation
01

Overview

Technetium Tc 99m albumin is a diagnostic radiopharmaceutical composed of the radioactive isotope technetium-99m (Tc-99m) complexed with human serum albumin (HSA). Depending on its physical formulation—soluble, colloidal, or macroaggregated—it is used for a variety of scintigraphic imaging procedures. Soluble 99mTc-HSA is primarily utilized for blood pool scintigraphy and equilibrium radionuclide angiocardiography to evaluate cardiac function and ventricular ejection fraction. Colloidal and nanocolloidal forms are frequently employed in lymphoscintigraphy for sentinel lymph node mapping in oncology, particularly for breast, cervical, and endometrial cancers. Macroaggregated albumin (MAA) is the standard agent for lung perfusion imaging and is also used to detect venous thrombosis. The drug functions by distributing throughout the vascular or lymphatic compartments, where the decay of technetium-99m emits gamma radiation (140 keV) that is captured by a gamma camera to create detailed physiological images.

Brand names
VasculocisNanocollTechnescan HSAAlburesMacrotecPulmoliteDraximage MAA
Other names
Technetium Tc 99m albumin aggregatedTechnetium Tc 99m albumin colloidTechnetium Tc 99m albumin nanocolloid99mTc-labeled human serum albuminTechnetium-99m macroaggregated albuminTechnetium99m macroaggregated albuminTechnetium 99m macroaggregated albumin

Beyond the preview

Go deeper on technetium Tc 99m albumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc 99m albumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call